Recognition and handling of discordant negative human epidermal growth factor receptor 2 classification by Oncotype DX in patients with breast cancer.
Matthias
M
Christgen
Nadia
N
Harbeck
Oleg
O
Gluz
Ulrike
U
Nitz
Hans H
HH
Kreipe
D001943:Breast Neoplasms / Q000737:chemistry*; D005260:Female; D006801:Humans; D011785:Quality Assurance, Health Care; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods*
D018719:Erb-b2 Receptor Tyrosine Kinases